NurseNow Staffing announced last week that it had become a founding member of the Decentralized Trials & Research Alliance (DTRA), which launched last December as a collaborative effort of 50 life sciences and healthcare organizations seeking to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. NurseNow matches highly qualified nurses who want flexibility, fair pay, and freedom with clinical research organizations that have unique—and often immediate—needs.
DTRA unites industry stakeholders, including healthcare companies, regulators, patient groups, and research organizations, with a singular mission to make clinical trial participation widely accessible by advancing policies, research practices, and new technologies in decentralized clinical research.
Experts estimate that COVID-19 may set back non-pandemic clinical trials by several years due to prospective patients’ inability or reluctance to schedule visits at physical research locations. Decentralized approaches to conducting research facilitate participation by a more diverse patient population and could ease COVID-19-imposed difficulties for both patients and clinical investigators.
“Now is the time to share ideas and insights that will chart the future course of clinical trials, accelerating drug development and saving lives—and by taking part in the DTRA, NurseNow is demonstrating its leadership to drive change,” said Craig Lipset, DTRA co-convener, clinical innovation advisor, and a pioneer in decentralized trials. “We have a responsibility to advance the health of people with unmet medical needs, and by convening stakeholders from pharma companies, regulators, technology leaders, and patient communities, we can remove remaining barriers to adoption and impact patients today.”
Edited by Gary Cramer
